Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 13 March 2020 doi:10.20944/preprints202003.0226.v1 Article Potential Inhibitor of COVID-19 Main Protease (Mpro) from Several Medicinal Plant Compounds by Molecular Docking Study Siti Khaerunnisa 1,*, Hendra Kurniawan 2,3*, Rizki Awaluddin 4, Suhartati Suhartati5, Soetjipto Soetjipto 1,* 1 Departement of Medical Biochemistry, Faculty of Medicine, Airlangga University, Surabaya, East Java, Indonesia, 60132;
[email protected];
[email protected] 2 Departement of Medical and Surgical Nursing, Faculty of Health Science, University of Muhammadiyah Jember, Jember, East Java, Indonesia, 68121;
[email protected] 3 PhD Student, Tropical Disease Research Center, Faculty of Medicine. Khon Kaen University, Khon Kaen, Thailand, 40002;
[email protected] 4 Departement of Pharmacy, Faculty of Health Science, University of Darussalam Gontor, Ponorogo, East Java, Indonesia, 63471;
[email protected] 5 Departement of Medical Biochemistry, Faculty of Medicine, University of Wijaya Kusuma Surabaya, East Java, Indonesia, 60225;
[email protected] * Correspondence:
[email protected] ; Tel.: +6281233118194 (S.K.);
[email protected]; Tel.: +6281331340518 (S.S.);
[email protected] ; Tel.: +628113572277 (H.K.) Abstract: COVID-19, a new strain of coronavirus (CoV), was identified in Wuhan, China, in 2019. No specific therapies are available and investigations regarding COVID-19 treatment are lacking. Liu et al. (2020) successfully crystallised the COVID-19 main protease (Mpro), which is a potential drug target. The present study aimed to assess bioactive compounds found in medicinal plants as potential COVID-19 Mpro inhibitors, using a molecular docking study.